Issue 3/2018
Content (25 Articles)
The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials
Ting-Ting Zhao, Hao Xu, Hui-Mian Xu, Zhen-Ning Wang, Ying-Ying Xu, Yong-Xi Song, Song-Cheng Yin, Xing-Yu Liu, Zhi-Feng Miao
High adherence to the Western, Prudent, and Mediterranean dietary patterns and risk of gastric adenocarcinoma: MCC-Spain study
Adela Castelló, Nerea Fernández de Larrea, Vicente Martín, Verónica Dávila-Batista, Elena Boldo, Marcela Guevara, Víctor Moreno, Gemma Castaño-Vinyals, Inés Gómez-Acebo, Guillermo Fernández-Tardón, Rosana Peiró, Rocío Olmedo-Requena, Rocio Capelo, Carmen Navarro, Silvino Pacho-Valbuena, Beatriz Pérez-Gómez, Manolis Kogevinas, Marina Pollán, Nuria Aragonés
Development and validation of a risk assessment tool for gastric cancer in a general Japanese population
Masahiro Iida, Fumie Ikeda, Jun Hata, Yoichiro Hirakawa, Tomoyuki Ohara, Naoko Mukai, Daigo Yoshida, Koji Yonemoto, Motohiro Esaki, Takanari Kitazono, Yutaka Kiyohara, Toshiharu Ninomiya
Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis
Xingkang He, Wenrui Wu, Zhenghua Lin, Yue Ding, Jianmin Si, Lei-min Sun
In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients
Yasutoshi Kuboki, Christoph A. Schatz, Karl Koechert, Sabine Schubert, Janine Feng, Sabine Wittemer-Rump, Karl Ziegelbauer, Thomas Krahn, Akiko Kawano Nagatsuma, Atsushi Ochiai
An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma
Zongqiong Sun, Xiaofang Cheng, Yuxi Ge, Lin Shao, Yinghua Xuan, Gen Yan
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)
Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, Kazuhiro Nishikawa, Chikara Kunisaki, Satoshi Matsusaka, Yoshihiko Segawa, Masato Nakamura, Kinro Sasaki, Narutoshi Nagao, Yukimasa Hatachi, Yasuhiro Yuasa, Shinya Asami, Masahiro Takeuchi, Hiroshi Furukawa, Toshifusa Nakajima, Tomono Kawase, Ryohei Kawabata, Yutaka Kimura, Tetsuya Etou, Toshiki Masuishi, Hirochika Makino, Hidetaka Ono, Yusuke Izumisawa, Chikara Kunisaki, Kazuhiro Nishikawa, Junji Kawada, Satoshi Matsusaka, Ken Shimada, Yu Sunakawa, Yoshihiko Segawa, Masato Nakamura, Hitoshi Satomura, Kinro Sasaki, Narutoshi Nagao, Katsuyuki Kunieda, Akihito Tsuji, Hironaga Satake, Yukimasa Hatachi, Hisashi Ishikura, Yasuhiro Yuasa, Hiroshi Okitsu, Shinya Asami, Takahiro Ito, Kentaro Moriichi, Masazumi Takahashi, Yasutaka Takinishi, Takashi Sekikawa, Naoki Okumura, Shigemitsu Ueyama, Noriyuki Yamamura, Dai Manaka, Sachiko Oouchi, Ryuichiro Ohashi, Tomohiko Mannami, Kazuaki Tanabe, Takeshi Shiraishi
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06)
Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, Kazuhiro Nishikawa, Chikara Kunisaki, Satoshi Matsusaka, Yoshihiko Segawa, Masato Nakamura, Kinro Sasaki, Narutoshi Nagao, Yukimasa Hatachi, Yasuhiro Yuasa, Shinya Asami, Masahiro Takeuchi, Hiroshi Furukawa, Toshifusa Nakajima, Tomono Kawase, Ryohei Kawabata, Yutaka Kimura, Tetsuya Etou, Toshiki Masuishi, Hirochika Makino, Hidetaka Ono, Yusuke Izumisawa, Chikara Kunisaki, Kazuhiro Nishikawa, Junji Kawada, Satoshi Matsusaka, Ken Shimada, Yu Sunakawa, Yoshihiko Segawa, Masato Nakamura, Hitoshi Satomura, Kinro Sasaki, Narutoshi Nagao, Katsuyuki Kunieda, Akihito Tsuji, Hironaga Satake, Yukimasa Hatachi, Hisashi Ishikura, Yasuhiro Yuasa, Hiroshi Okitsu, Shinya Asami, Takahiro Ito, Kentaro Moriichi, Masazumi Takahashi, Yasutaka Takinishi, Takashi Sekikawa, Naoki Okumura, Shigemitsu Ueyama, Noriyuki Yamamura, Dai Manaka, Sachiko Oouchi, Ryuichiro Ohashi, Tomohiko Mannami, Kazuaki Tanabe, Takeshi Shiraishi
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm
Akira Sawaki, Yasuhide Yamada, Kensei Yamaguchi, Tomohiro Nishina, Toshihiko Doi, Taroh Satoh, Keisho Chin, Narikazu Boku, Yasushi Omuro, Yoshito Komatsu, Yasuo Hamamoto, Wasaburo Koizumi, Shigehira Saji, Manish A. Shah, Eric Van Cutsem, Yoon-Koo Kang, Junko Iwasaki, Hiroshi Kuriki, Wataru Ohtsuka, Atsushi Ohtsu
A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer
Yusuke Sasaki, Satoru Iwasa, Shunsuke Okazaki, Masahiro Goto, Yasushi Kojima, Atsushi Naganuma, Kengo Nagashima, Yushi Nagai, Hidekazu Hirano, Yoshitaka Honma, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
Kazumasa Fujitani, Yukinori Kurokawa, Atsushi Takeno, Shunji Endoh, Takeshi Ohmori, Junya Fujita, Makoto Yamasaki, Shuji Takiguchi, Masaki Mori, Yuichiro Doki
Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment
Sun Young Kim, Min Joo Yoon, Young Iee Park, Mi Jung Kim, Byung-Ho Nam, Sook Ryun Park
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
Akitaka Makiyama, Kohei Arimizu, Gen Hirano, Chinatsu Makiyama, Yuzo Matsushita, Tsuyoshi Shirakawa, Hirofumi Ohmura, Masato Komoda, Keita Uchino, Kyoko Inadomi, Shuji Arita, Hiroshi Ariyama, Hitoshi Kusaba, Yudai Shinohara, Miyuki Kuwayama, Tatsuhiro Kajitani, Hisanobu Oda, Taito Esaki, Koichi Akashi, Eishi Baba
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma
Andrew J. Martin, Emma Gibbs, Katrin Sjoquist, Nick Pavlakis, John Simes, Tim Price, Jenny Shannon, Sanjeev Gill, Vikram Jain, Geoffrey Liu, George Kannourakis, Yeul Hong Kim, Jin Won Kim, David Goldstein
Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study
Waku Hatta, Takuji Gotoda, Tsuneo Oyama, Noboru Kawata, Akiko Takahashi, Yoshikazu Yoshifuku, Shu Hoteya, Masahiro Nakagawa, Masaaki Hirano, Mitsuru Esaki, Mitsuru Matsuda, Ken Ohnita, Kohei Yamanouchi, Motoyuki Yoshida, Osamu Dohi, Jun Takada, Keiko Tanaka, Shinya Yamada, Tsuyotoshi Tsuji, Hirotaka Ito, Yoshiaki Hayashi, Tomohiro Nakamura, Naoki Nakaya, Tooru Shimosegawa
Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis
Sunpyo Lee, Kee Don Choi, Minkyu Han, Hee Kyong Na, Ji Yong Ahn, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Ho June Song, Gin Hyug Lee, Jeong-Hwan Yook, Byung Sik Kim, Hwoon-Yong Jung
Short-term outcomes and nutritional status after laparoscopic subtotal gastrectomy with a very small remnant stomach for cStage I proximal gastric carcinoma
Haruna Furukawa, Yukinori Kurokawa, Shuji Takiguchi, Koji Tanaka, Yasuhiro Miyazaki, Tomoki Makino, Tsuyoshi Takahashi, Makoto Yamasaki, Kiyokazu Nakajima, Masaki Mori, Yuichiro Doki
Optimal minimally invasive surgical procedure for gastric submucosal tumors
Yoshiaki Shoji, Hiroya Takeuchi, Osamu Goto, Kazunori Tokizawa, Rieko Nakamura, Tsunehiro Takahashi, Norihito Wada, Hirofumi Kawakubo, Naohisa Yahagi, Yuko Kitagawa
Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful?
Haruna Furukawa, Manabu Ohashi, Michitaka Honda, Koshi Kumagai, Souya Nunobe, Takeshi Sano, Naoki Hiki
Factors influencing health-related quality of life after gastrectomy for cancer
Hylke J. F. Brenkman, Juul J. W. Tegels, Jelle P. Ruurda, Misha D. P. Luyer, Ewout A. Kouwenhoven, Werner A. Draaisma, Donald L. van der Peet, Bas P. L. Wijnhoven, Jan H. M. B. Stoot, Richard van Hillegersberg
Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma
Joonas H. Kauppila, Cecilia Ringborg, Asif Johar, Jesper Lagergren, Pernilla Lagergren
Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial
Marco Catarci, Manuele Berlanda, Giovanni Battista Grassi, Francesco Masedu, Stefano Guadagni
Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis
Leila Sisic, Moritz J. Strowitzki, Susanne Blank, Henrik Nienhueser, Sara Dorr, Georg Martin Haag, Dirk Jäger, Katja Ott, Markus W. Büchler, Alexis Ulrich, Thomas Schmidt
Priority of lymph node dissection for proximal gastric cancer invading the greater curvature
Yukio Maezawa, Toru Aoyama, Takanobu Yamada, Kazuki Kano, Tsutomu Hayashi, Tsutomu Sato, Takashi Oshima, Yasushi Rino, Munetaka Masuda, Takashi Ogata, Haruhiko Cho, Takaki Yoshikawa
How to adjust endoscopic findings to histopathological findings of the stomach: a “histopathology-oriented” correspondence method helps to understand endoscopic findings
Yasuko Fujita, Mitsuo Kishimoto, Osamu Dohi, Kazuhiro Kamada, Atsushi Majima, Reiko Kimura-Tsuchiya, Nobuaki Yagi, Hideyuki Konishi, Yuji Naito, Yoshinori Harada, Hideo Tanaka, Eiichi Konishi, Tamotsu Sugai, Akio Yanagisawa